S. Aguilar

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

Yolanda Fernández, Juan D Gispert, Santiago Rojas, 2012, Nature Medicine.

TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

J. Tabernero, P. Nuciforo, R. Dienstmann, 2018, The Journal of clinical investigation.

1 β-catenin Confers Resistance to PI 3 K and AKT inhibitors and Subverts FOXO 3 a to Promote Metastasis in Colon Cancer

J. Baselga, J. Tabernero, S. Schwartz, 2012 .

Kidney cancer PDOXs reveal patient‐specific pro‐malignant effects of antiangiogenics and its molecular traits

J. Carles, S. Aguilar, A. Amadori, 2020, EMBO molecular medicine.

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

R. Salazar, J. Tabernero, P. Nuciforo, 2022, International journal of molecular sciences.

Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials

J. Carles, E. Felip, P. Nuciforo, 2020, JCO precision oncology.

Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients.

E. Felip, R. Dienstmann, I. Braña, 2023, Oral oncology.

Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

M. Fraga, D. Pisano, C. López-Otín, 2015, Oncotarget.

Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis

Allison P. Heath, Marilyn M. Li, Jena V. Lilly, 2022, Scientific Reports.

Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

M. Fraga, D. Pisano, C. López-Otín, 2015, Oncotarget.

ESMO Scale for Clinical Actionability of Molecular Targets driving targeted treatment in patients with cholangiocarcinoma.

P. Nuciforo, R. Dienstmann, S. Aguilar, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.